Skip to content
healthcare.dev

Ticagrelor

NDC 11788-157, Ticagrelor, tablet, from AiPing Pharmaceutical, Inc.

Product NDC
11788-157
Status
Listed
Labeler
AiPing Pharmaceutical, Inc
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219006
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/11788-157 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TICAGRELOR60 mg/1

Pharmacologic classes

Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; P-Glycoprotein Inhibitors [MoA]; P2Y12 Platelet Inhibitor [EPC]; P2Y12 Receptor Antagonists [MoA]

Package NDCNDC-11Package
11788-157-601178801576060 TABLET in 1 BOTTLE (11788-157-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4ecb82df-fad2-1f6c-e063-6294a90a9d19
  • NADAC price for package 11788015760

    GET /v1/drugs/nadac/11788015760

Use it

Look up 11788-157 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/11788-157 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 11788-157. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.